Related Experiment Videos

Maturation and growth of renal function: dosing renally cleared drugs in children

W L Hayton1

  • 1Division of Pharmaceutics, College of Pharmacy, The Ohio State University, 500 West 12th Ave., Columbus, OH 43210-1291, USA. hayton.1@osu.edu

AAPS Pharmsci
|December 14, 2001
PubMed

Insights

A new model quantifies renal function maturation in children, estimating glomerular filtration rate, active tubular secretion, and renal plasma flow. This model aids in adjusting pediatric drug dosages based on age and weight.

Area of Science:

  • Pediatric Nephrology
  • Pharmacokinetics
  • Mathematical Modeling

Background:

  • Renal function parameters (RFPs) like glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (QR) undergo significant maturation during childhood.
  • Accurate characterization of these parameters is crucial for understanding drug disposition and optimizing pediatric dosing regimens.

Purpose of the Study:

  • To develop and validate a mathematical model that describes the maturation and growth of key renal function parameters in healthy children.
  • To provide a tool for estimating pediatric renal function based on age and body weight, facilitating accurate drug dosage calculations.

Main Methods:

  • A model was developed using published RFP data from 63 healthy children aged 2 days to 12 years.
  • The model assumes exponential maturation from immature to mature levels, incorporating allometric scaling with body weight.
  • Nonlinear least-squares regression was employed to fit the model to age- and weight-specific RFP data.

Main Results:

  • For GF, the maturation half-life was 7.9 months, with 90% maturation achieved at 26 months. The body weight exponent was 0.662, and the ratio of mature to immature function (c/a) was 3.1.
  • For AS and QR, maturation half-lives were approximately 3.8 months, with a c/a ratio of about 1.8.
  • The model successfully characterized the age- and weight-dependent changes in pediatric renal function.

Conclusions:

  • The developed model provides a robust framework for understanding renal function maturation in children.
  • This model can be utilized to estimate age- and weight-appropriate dosing regimens for renally eliminated drugs in pediatric populations.
  • Accurate pharmacokinetic modeling based on maturation of renal function is essential for safe and effective pediatric pharmacotherapy.

Related Concept Videos